Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
715
-
Total 13F shares, excl. options
-
67.2M
-
Shares change
-
-2.25M
-
Total reported value, excl. options
-
$25.6B
-
Value change
-
-$805M
-
Put/Call ratio
-
0.43
-
Number of buys
-
325
-
Number of sells
-
-317
-
Price
-
$382.47
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2023
790 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2023.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 715 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.2M shares
of 71.9M outstanding shares and own 93.45% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.95M shares), BlackRock Inc. (7.97M shares), Bank of New York Mellon Corp (3.44M shares), STATE STREET CORP (3.27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.84M shares), APG Asset Management N.V. (2.26M shares), FRANKLIN RESOURCES INC (2.17M shares), T. Rowe Price Investment Management, Inc. (1.73M shares), GEODE CAPITAL MANAGEMENT, LLC (1.59M shares), and Durable Capital Partners LP (1.28M shares).
This table shows the top 715 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.